Institutional members access full text with Ovid®

Share this article on:

Telephone Consultations for Tissue Plasminogen Activator Administration in Acute Stroke

Sattin, Justin A. MD

doi: 10.1212/01.CON.0000446111.97667.11
Ethical Perspectives

ABSTRACT Effective treatment for acute ischemic stroke has been available for 17 years, but wide geographic variability remains in timely access to neurologic expertise and other components of stroke systems of care. Telemedical technology can be used to improve such access, but it is debatable whether neurologists have an ethical obligation to provide consultation regarding tissue plasminogen activator use via the telephone. This article examines whether neurologists are ethically obligated to provide telephone-mediated acute stroke consultation.

Address correspondence to Dr Justin A. Sattin, Department of Neurology, 1685 Highland Ave, Madison, WI 53711, sattin@neurology.wisc.edu.

Relationship Disclosure: Dr Sattin reports no disclosure.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Sattin reports no disclosure.

© 2014 American Academy of Neurology
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website